EVIDENCE-BASED INVESTING IN HEALTHCARE & LIFE SCIENCES.

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.

DENALI

NATIONAL PARK & RESERVEALASKA

"THERE IS SO MUCH LEFT TO DISCOVER."

PETER KOLCHINSKY, MANAGING DIRECTOR
& PORTFOLIO MANAGER

YELLOWSTONE

NATIONAL PARKIDAHO, MONTANA, WYOMING

ABOUT US

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.

TOP

OUR VALUES:

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

RA Capital’s scientifically trained research team is intensely data driven in its continual effort to identify early breakthroughs and originate conviction in new ideas. The team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.

RA Capital’s approach to research and due diligence is highly collaborative, encouraging outreach and exchange of knowledge within the biotechnology community at conferences, in the classroom, and through a targeted publications program.

RA Capital also offers an Executive-in-Residence program for experienced professionals seeking thought partners and a platform from which to survey diverse competitive landscapes in search of worthy projects.

OUR VALUES:

WE ORIGINATE CONVICTION

WE DO NOT BORROW IT FROM OTHERS

WE EXPECT AND STRIVE TO

INSPIRE THE BEST IN EVERYONE

WE DO NOT FEAR THE UNFAMILIAR

WE DO NOT LET CONVENTION
STAND IN THE WAY OF WHAT IS RIGHT

WE COMMUNICATE
WITH PASSION

WE ARE DATA-DRIVEN
AND CHALLENGE ASSUMPTIONS

WE ARE PERSISTENTLY CURIOUS

AND HUMBLED BY WHAT IS LEFT TO LEARN

WE ADMIT OUR MISTAKES
AND SHARE LESSONS LEARNED

WE ENCOURAGE BRAINSTORMING

BUT EXECUTION IS REWARDED

WE PRESERVE THE RIGHT TO CHANGE OUR MIND

WE ADDRESS THE
ELEPHANT IN THE ROOM

WE WORK WITH A
SENSE OF URGENCY

WE VALUE OUR RELATIONSHIPS

AND ARE POSITIVE, RESPECTFUL, AND OPEN-MINDED

"WE OWE A DEBT TO THE PEOPLE WHO HAVE MENTORED US, AND WE IN TURN HAVE A RESPONSIBILITY TO TURN OUR HARD WON LESSONS INTO A SOLID FOUNDATION FOR OUR INDUSTRY'S EMERGING INNOVATORS AND LEADERS."

RAJEEV SHAH, MANAGING DIRECTOR
& PORTFOLIO MANAGER

SEQUOIA & KINGS CANYON

NATIONAL PARKCALIFORNIA

THE TEAM

Investment team is supported by a diverse group of scientific researchers and writers that help facilitate the firm’s technical and clinical research efforts.

TOP

"We all start here as scientists who know the importance of asking the right questions and then learn to assimilate more knowledge than one might think possible so that we can recognize an elegant and robust investment thesis.

SEEING OUR NEWEST TEAM MEMBERS MAKE THEIR FIRST CONFIDENT DATA-DRIVEN PREDICTION IS INCREDIBLY REWARDING."

TOMAS KISELAK, MANAGING DIRECTOR

ARCHES

NATIONAL PARKUTAH

CROSS-OVER

PORTFOLIO

RA Capital invests in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.

TOP

CONTACT US

RA CAPITAL MANAGEMENT, LLC
20 Park Plaza, Suite 1200
Boston, MA 02116

T: 617.778.2500

www.RACAP.com

TOP

“WE ARE PRIVILEGED TO BE TAUGHT EVERYDAY BY THE GREATEST SCIENTIFIC MINDS IN THE INDUSTRY AND ACADEMIA.

Our curiosity and work drive us to restore context to data and knowledge, from which emerge remarkable insights, each one potentially inspiring investment in outstanding people and technologies. But to have the greatest positive social impact, we must share those insights in an effort to enrich discourse and spark collaboration among all stakeholders, including patients, physicians, innovators, researchers, policy makers, and the next generation searching for inspiration.”

PETER KOLCHINSKY, MANAGING DIRECTOR
& PORTFOLIO MANAGER

EVERGLADES

NATIONAL PARKFLORIDA

OUTREACH

From class rooms to board rooms, we believe in sharing what we have learned from thousands of case studies about clinical trials, product development, and business/finance strategy with our portfolio companies and, through our outreach efforts, with the broader healthcare and life science community.

TOP

The biotechnology industry is a vibrant community of researchers, business executives, and investors often charting new territory in the pursuit of innovation. After many years of investing in both public and private companies across the therapeutic, diagnostic, and device landscapes, our team has come to recognize some of the patterns of success and failure. We believe in openly contributing what we know; we have shared our perspective on valuation methods, business models, clinical trial design, and other best practices gleaned from hundreds of case studies in boardrooms, classrooms, conferences, and articles.

For example, we have helped entrepreneurs identify comparables for their businesses, guided management teams in prioritizing their development programs, helped companies gauge when they might be IPO-ready, and informed companies’ decision about how much capital to raise, when to raise it, which banks to work with, and which investors to talk to.

On occasion, we have also had the pleasure of speaking with students near and far (University of Helsinki currently holds the record/tops the charts/is the current leader for furthest distance). We typically discuss trends in innovation, how we invest, and risks in the healthcare and life science industries; we hope they remember us when they someday launch companies and are looking for capital.

We do our best to make time for outreach and welcome all queries – please contact Katie Maher at kmaher@racap.com.